Int J Med Sci 2021; 18(3):615-625. doi:10.7150/ijms.51589 This issue Cite

Research Paper

MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression

Binbin Li1*, Jiaxuan Liu1*, Xuan Xin1,2*, Lifen Zhang1, Jiaming Zhou1,3, Chunyan Xia1, Weijian Zhu1, Hongyu Yu1✉

1. Department of Pathology, Changzheng Hospital, Navy Medical University (Second Military Medical University), Shanghai 200003, China.
2. Department of Pathology, No. 960 Hospital of People' Liberation Army, Jinan 250031, China.
3. Department of Pathological Anatomy, Nantong University, Nantong 226001, China.
*These authors contributed equally to this work.

Citation:
Li B, Liu J, Xin X, Zhang L, Zhou J, Xia C, Zhu W, Yu H. MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression. Int J Med Sci 2021; 18(3):615-625. doi:10.7150/ijms.51589. https://www.medsci.org/v18p0615.htm
Other styles

File import instruction

Abstract

Normally, there are multiple microRNAs involved in the pathogenesis of liver fibrosis. In our work, we aimed at identifying the role of miR-34c in the hepatic stellate cell (HSC) activation and liver fibrosis and its potential mechanism. Our results have shown that during natural activation of HSC, the level of miR-34c was increased significantly whereas acyl-CoA synthetase long-chain family member-1(ACSL1), which is a key enzyme can affect fatty acid(FA) synthesis, was decreased. A double fluorescence reporter assay further confirmed that ACSL1 is a direct target gene of miR-34c. Moreover, the inhibition of miR-34C can attenuate the synthesis of collagen in HSC-T6. In our rescue assay, ACSL1 expression was 1.49-fold higher compared to normal control cells which were transfected with the miR-34c inhibitor in a stable low expression ACSL1 cell line. While at the same time, α-SMA and Col1α expression decreased by 18.22% and 2.58%, respectively. Moreover, we performed an in vivo model using dimethylnitrosamine (DMN) in conjunction with the miR-34c agomir, combined with the treatment of DMN and the miR-34c agomir can increase liver fibrosis. Meanwhile, the degree of hepatic fibrosis was increased and lipid droplets reduced dramatically in rats and HSC-T6 cell treated with miR-34c mimics alone compared to untreated groups. Our results indicate that miR-34c plays an essential role in liver fibrosis by targeting ACSL1 closely associated with lipid droplets, and it might be used as a potential therapeutic target.

Keywords: miR-34c, ACSL1, liver fibrogenesis, fatty acid, lipid metabolism


Citation styles

APA
Li, B., Liu, J., Xin, X., Zhang, L., Zhou, J., Xia, C., Zhu, W., Yu, H. (2021). MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression. International Journal of Medical Sciences, 18(3), 615-625. https://doi.org/10.7150/ijms.51589.

ACS
Li, B.; Liu, J.; Xin, X.; Zhang, L.; Zhou, J.; Xia, C.; Zhu, W.; Yu, H. MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression. Int. J. Med. Sci. 2021, 18 (3), 615-625. DOI: 10.7150/ijms.51589.

NLM
Li B, Liu J, Xin X, Zhang L, Zhou J, Xia C, Zhu W, Yu H. MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression. Int J Med Sci 2021; 18(3):615-625. doi:10.7150/ijms.51589. https://www.medsci.org/v18p0615.htm

CSE
Li B, Liu J, Xin X, Zhang L, Zhou J, Xia C, Zhu W, Yu H. 2021. MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression. Int J Med Sci. 18(3):615-625.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image